NEW YORK, Nov. 14 (GenomeWeb News) - In a formal response to Promega's announcement of a lawsuit against Hoffman La Roche for an "overcharging scheme," Roche said today that Promega's claims lack merit and that Promega's decision to announce the suit "is simply a litigation tactic."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.